Skip to main content
. 2021 Jun 22;24(3):330–343. doi: 10.4048/jbc.2021.24.e32

Figure 1. NORAD is downregulated in BC and negatively correlates with tumor differentiation in patients with BC.

Figure 1

(A) Analysis of the StarBase database to examine NORAD expression in normal and BC tissues. (B) qRT-PCR analysis of the relative expression of NORAD in 46 pairs of BC and matched normal tissues. (C) qRT-PCR analysis of the relative expression of NORAD in four BC cell lines and the normal breast cell line, MCF-10A. (D) qRT-PCR analysis of NORAD expression in BC tissues with different differentiation status.

NORAD = non-coding RNA activated by DNA damage; BC = breast cancer; qRT-PCR = quantitative real-time polymerase chain reaction.

*p < 0.05, †p < 0.01, and ‡p < 0.001.